Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The liquid format supports analytical testing, stability assessment, and controlled laboratory applications without implying consumer or clinical use
a TB-500 safety study (NCT07487363) is recruiting but has no results
The liquid spray format provides a standardized and convenient delivery system for controlled scientific research applications
The result is an injectable solution with unknown sterility status, unknown endotoxin levels, and unknown particulate content
Cycles often run 8-12 weeks with breaks between
Research shows it: Accelerates angiogenesis (blood vessel formation), which brings nutrients and growth factors to injured tissue Upregulates the FAK-paxillin pathway , which drives fibroblast migration and collagen synthesis Modulates the NO system , improving blood flow to injury sites Protects the gut lining (for oral administration), which is relevant if you are taking NSAIDs for pain BPC-157 works best when delivered close to the injury siteeither via subQ injection near the problem area or oral administration for gut/systemic issues
:max_bytes(150000):strip_icc()/VWH-GettyImages-1469751146-5eff6dd0b38449ff9dca9313c7c393d5.jpg)
